Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,789,356
  • Shares Outstanding, K 97,400
  • Annual Sales, $ 11,555 M
  • Annual Income, $ 823,800 K
  • 60-Month Beta 1.09
  • Price/Sales 1.76
  • Price/Cash Flow 11.33
  • Price/Book 2.64
Trade LH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 7.36
  • Number of Estimates 8
  • High Estimate 8.56
  • Low Estimate 6.16
  • Prior Year 2.86
  • Growth Rate Est. (year over year) +157.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
200.46 +12.61%
on 12/31/20
227.32 -0.70%
on 01/19/21
+20.63 (+10.06%)
since 12/18/20
3-Month
192.79 +17.09%
on 11/10/20
227.32 -0.70%
on 01/19/21
+25.83 (+12.92%)
since 10/19/20
52-Week
98.02 +130.30%
on 03/19/20
227.32 -0.70%
on 01/19/21
+48.74 (+27.54%)
since 01/17/20

Most Recent Stories

More News
Labcorp Appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer, Labcorp Diagnostics

Labcorp, (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical Officer of Labcorp Diagnostics, following the retirement...

LH : 225.74 (+0.91%)
Testing Space in Focus Again Thanks to New Wave of Coronavirus

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

BDX : 260.77 (-0.37%)
DGX : 125.99 (+1.29%)
HOLX : 75.99 (-0.14%)
QGEN : 54.16 (+1.80%)
ABT : 112.57 (+1.14%)
LH : 225.74 (+0.91%)
QDEL : 201.24 (-1.59%)
Pandemic Cases in the U.S. Are Now At Dangerous All-Time Highs

Pandemic deaths are now at unprecedented levels in the U.S. In fact, the country has now averaged ...

DM.VN : 0.190 (-2.56%)
DTMXF : 0.1515 (+16.54%)
AC.TO : 23.05 (+0.35%)
ACDVF : 18.0900 (+0.50%)
PFE : 36.73 (+0.08%)
LH : 225.74 (+0.91%)
AAL : 15.97 (+1.33%)
DM : 24.20 (+1.89%)
Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021

Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021, and then will host a...

LH : 225.74 (+0.91%)
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to provide genomic sequencing of...

LH : 225.74 (+0.91%)
Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare

Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics, was recognized by Modern Healthcare as one...

LH : 225.74 (+0.91%)
LabCorp's (LH) Covance Arm Stays Robust Amid Procedure Delay

Apart from COVID-19 supports, LabCorp (LH) is making significant strides in other businesses.

SYK : 242.07 (+0.03%)
MCK : 182.47 (-1.06%)
MMSI : 55.93 (+0.38%)
LH : 225.74 (+0.91%)
Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference

Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare...

JPM : 138.04 (-0.43%)
LH : 225.74 (+0.91%)
Top Ranked Growth Stocks to Buy for January 4th

Top Ranked Growth Stocks to Buy for January 4th

ODP : 45.93 (+0.16%)
LH : 225.74 (+0.91%)
KNX : 43.69 (-0.68%)
ABG : 160.39 (-1.27%)
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.

DVA : 118.10 (-0.55%)
MCK : 182.47 (-1.06%)
LH : 225.74 (+0.91%)
IDXX : 484.93 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class...

See More

Key Turning Points

3rd Resistance Point 234.56
2nd Resistance Point 230.94
1st Resistance Point 228.34
Last Price 225.74
1st Support Level 222.12
2nd Support Level 218.50
3rd Support Level 215.90

See More

52-Week High 227.32
Last Price 225.74
Fibonacci 61.8% 177.93
Fibonacci 50% 162.67
Fibonacci 38.2% 147.41
52-Week Low 98.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar